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ABSTRACT 
Waardenburg syndrome (WS) is the most common form of syndromic deafness in schools 
for the hearing impaired in Southern Africa. It is an autosomal dominantly inherited 
disorder characterised by varying combinations of sensorineural deafness, pigmentary 
disturbances of the hair, skin and irides and dystopia canthorum. It has previously been 
demonstrated by linkage analysis that Waardenburg syndrome type I is linked to the PAX3 
gene at 2q35, while WS type II, where the phenotype does not include dystopia 
canthorum, is not linked to this locus. Families with WS type I have been shown to have 
different mutations in the PAX3 gene, thereby confirming the linkage results and 
demonstrating allelic heterogeneity. 
The aims of the study which forms the subject of this dissertation, were to determine the 
possibility of linkage of the disorder, as well as to elucidate the underlying molecular 
defect in the Southern African families with WS. Ten WS families were assessed 
clinically. 142 family members agreed to partake in the molecular study; 72 of these were 
affected. Of these families, 7 had WS I and 3 had WS II. A further 37 affected 
individuals with no family history were also incorporated into the molecular investigation. 
The WS type I families were found to be potentially linked to PAX3, while the WS type II 
families were not linked. Mutation screening of the exons of PAX3 has been performed in 
SA families in which the disorder was linked to this locus as well as the WS I sporadic 
individuals. A mutation in PAX3 was confirmed in 3 families and is probable in another, 
although not confirmed. A silent polymorphism cosegregating with the disorder, was 
identified in another of the SA families. Molecular investigation proved that there was 
intragenic heterogeneity, with no correlation between the position of the mutation causing 
WS I and the resulting phenotype. 
Linkage analysis was employed to locate gene loci which may be involved in the 
pathogenesis of WS type II. The genotypes of one of the type II families were indicative 
of linkage of the disorder in this family to a gene on chromosome 3, which had previously 
been located. Linkage analysis indicated a- good probability of WS type II in another SA 
family being associated with markers on chromosome 20. 
The elucidation of the pathogene~is of WS has introduced another level of complexity to 
the disorder. Three or more loci are responsible for the different types of WS and it is 
probable that these loci are all intragenically heterogeneous. This investigation provides 
the basis for further study of the genes which function during embryogenesis and the way 
in which the disruption of these genes causes intrafamilial variability of deafness and other 
phenotypic characteristics of WS. 
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PLAN OF THE THESIS 
Chapter 1 deals with the background to Waardenburg syndrome (WS) beginning 
with the perceptions of genetic deafness in the early 1800's and the original 
delineation of WS. The clinical characteristics are discussed with emphasis on the 
variability of the phenotype. The molecular background, which forms the basis for 
this dissertation , deals with the search for the genes involved in the pathogenesis of 
WS. As developmental abnormalities are fundamental to the manifestation of the 
phenotype, the embryonic environment is discussed to put into context the highly 
ordered events which are disrupted in WS. 
The situation with regard to WS in Southern Africa (SA) is dealt with in -chapter 2. 
The identification and clinical analysis of the families, which form part of the 
molecular investigation, are described. 
Linkage analysis was necessary to distinguish which families were appropriate for 
mutation screening of the PAX3 gene and to investigate the possibility of other gene 
loci. Chapter 3 describes the methodology of the linkage procedure and the results 
of this analysis. 
The methods used for the analysis of the mutations underlying WS in the SA 
families are described in chapter 4. The elucidation of these mutations was the 
primary aim of this study. The results and discussion of the mutation analysis are 
presented in chapter 5. 
The conclusions for each aspect of the study are discussed in detail at the end of 
each chapter. Chapter 6 provides a final comment on the study as a whole. 
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CHAPTER! 
INTRODUCTION 
CHAPTER 1. INTRODUCTION 
1.1. THE HISTORY OF INHERITED DEAFNESS 
Until the middle of the 19th century heredity was not generally recognised as a 
cause of deafness. Information acquired from the Irish census of 1857 enabled 
William Wilde to observe that "the transmission of diseases by hereditary taint or 
family peculiarity ... is very manifest among the deaf and dumb". In addition he 
concluded that the occurrence of deafness was comparatively higher when 
consanguineous marriage had taken place, and that there was an excess of males 
among congenitally deaf patients. He had thus unknowingly identified the three 
forms of inheritance of this disease - autosomal dominant, recessive and X-linked. 
In 1882 Politzer wrote: "The most frequent causes of congenital deafness are: 
hereditary, including direct transmission from the parents as well as indirect 
transmission from forefathers, and marriage between blood relations" This 
statement, although not based on Wilde's work, confirmed the acceptance of the 
concept of hereditary deafness. 
Some of the consequences of these findings were not favorable to the well being of 
those with genetic deafness. In a memoir, privately published and then presented to 
the National Academy of Sciences in 1883, Alexander Bell tried to discourage 
marriage between deaf individuals because he feared that "the intermarriage of such 
persons would be calamitous to their offspring" and would produce a "defective 
race of human beings". At the close of the 19th century, Love refuted a number of 
Bell's assumptions after much research into the deaf population. He concluded that 
there were many forms of deafness and that they were transmitted by various modes 
of inheritance. 
It is now well recognised that there are numerous gene tics disorders in which 
hearing loss is a major feature. In some, additional clinical manifestations facilitate 
precise diagnosis , as in the Waardenburg syndrome, which form s the subject of this 
dissertation . In others, which are catergorised as undifferentiated or non-syndromic 
deafness , the only common feature in the phenotype is hearing loss ; these disorders 
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are usually classified by their mode of inheritance. There is little doubt that there is 
considerable heterogeneity in many genetic deafness syndromes and it can be 
foreseen that the application of molecular biology will elucidate this situation. 
1.2. THE CLINICAL ASPECTS OF W AARDENBURG SYNDROME 
1.2.1. Delineation of the syndrome 
A deaf and mute child was presented by Klein at a meeting of the Swiss Society of 
Genetics in 194 7_. Her clinical phenotype involved depigmentation of the hair and 
skin, blue irides and malformations of the arms. In 1948 Waardenburg presented a 
patient with similar clinical manifestations to the Ophthalmology Society of Utrecht. 
This 72 year old man had abnormally spaced palpebral fissures and pale blue irides, 
as well as deafness. The similarity of this patient to the girl presented by Klein 
prompted Waardenburg to undertake a diagnostic survey in several institutions for 
deaf-mutes in the Netherlands. Of a total of 1050 patients examined, 13 were found 
to have the condition. Family studies were initiated through these individuals and 
in 1951 Waardenburg published his findings and delineated this genetic disorder. 
He described the syndrome as a combination of six characteristics: 
1. Lateral displacement of the medial canthi, combined with dystopia of the lacrimal 
puncta and blerpharophimosis; 
2. prominent broad root of nose; 
3. growing together of the eyebrows, with hypertrichosis of their medial portions; 
4. white forelock, as a form of partial albinism; 
5. partial or total heterochromia of the irides; 
6. deaf-mutism or some degree of congenital deafness. 
Waardenburg concluded that the syndrome was inherited as an autosomal dominant 
trait, with variable expressivity and incomplete penetrance. 
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1.2.2. The variable phenotype 
Waardenburg syndrome (WS) has been described in populations all over the world 
and occurs in about 2 - 3 % of all children attending special schools for the deaf. 
The question of heterogeneity was addressed when Arias (1971) differentiated two 
separate forms of WS, distinguishable by the presence (type I) or absence (type II) 
of dystopia canthorum. To define dystopia quantitatively, the WARD index was 
formulated by Arias (1971) and Arias and Mota (1978). Using interocular 
measurements, as shown in Figure 1.1, this provided an objective biometric index. 
A 
a 
B 
C 
Figure 1.1. The anatomical basis for the interocular measurements used for the 
quantification of dystopia canthorum. A Normal situation; B dystopia 
canthorum (Taken from Hageman and Delleman, 1977). 
The WARD index is calculated as follows: 
W=X+Y+a/b 
where x = 2a - <0.2199c + 3.909) 
C 
and y = 2a - {0.2497b + 3.909) 
b 
a = inner canthal distance 
b = interpupillary distance· 
c = outer canthal distance 
Dystopia canthorum is said to be present when W ;::: 2.07. Non-apparent dystopia 
(NAD) is diagnosed when the phenotype is clinically ambiguous, the patient is 
related to a typical WS I case, other characteristics of WS I are present and the W 
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index ~ 1.87 < 2.07. Non-penetrance occurs when the phenotype is as for NAD, 
but W ~ 1. 87, ie. in the non-dystopic range. 
By quantitating the dystopia canthorum with biometric parameters many "non 
penetrant" obligate carriers were shown to have non-apparent dystopia (Arias and 
Mota, 1978). Arias and Mota also demonstrated, using the W index, that the 
penetrance for dystopia canthorum is almost 100% for WS type I pedigrees. 
The distinction between the two types of WS is important as the frequency of 
deafness for families with WS I is approximately 20%, whereas the frequency in 
WS II is 50 % . This situation has considerable implications for genetic counselling. 
Deafness in WS is not only variable in penetrance, but is also, as with the other 
characteristics, inconsistent in expression. Four types of hearing loss have been 
described from audiological studies of WS patients. Fisch (1959) reported a 
bilateral hearing loss with residual hearing in the low frequencies and a moderate 
unilateral hearing deficit with loss in the middle and lower frequencies. Bilateral 
severe hearing loss in all frequencies and unilateral profound deafness were 
described in WS patients by Hageman (1977). Intrafamilial variability in 
phenotypic expression further complicates genetic counselling. 
The fifth characteristic described by Waardenburg, that of partial or total 
heterochromia irides, has been broadened to include hypoplastic, isochromic blue 
irides. Waardenburg omitted these individuals from his study, but his belief that 
these occular changes were part of the syndrome was substantiated when "Negroid" 
individuals with blue eyes and other signs of WS were reported (Di George et al., 
1960). Since blue eyes are extremely rare in the black population, their frequent 
association with WS indicates that this feature is an expression of heterochromia. 
The unusually pale blue colour is due to hypoplasia and structural alterations of the 
iris stroma. 
The white forelock can be represented by a blaze of white hair or by just a few 
strands. Greying of the eyebrows and premature greying of the hair may represent 
the equivalent of a white forelock in some individuals. Depigmentation of the skin, 
presenting as patchy leukoderma, has also been reported (Hageman and Delleman , 
1977; Wang et al., 1981). 
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Skeletal dysplasia, with fused joints and underdeveloped muscles in the upper limbs, 
has been associated with the typical features of WS and is known as Klein-
Waardenburg syndrome or WS III. Sheffer and Zlotogora (1992) confirmed that 
this very rare syndrome exists as a separate entity to WS and has an autosomal 
dominant pattern of inheritance. WS IV (Waardenburg-Shah syndrome) manifests 
as Hirschsprung disease with pigmentary anomalies. The white forelock and 
depigmentation of the skin are similar to WS I, but the patients lack dystopia 
canthorum, deafness and the irides have an unusually light brown colour. 
Abnormalities which are occasionally associated with WS are cleft lip/palate, spina 
bifida (De Saxe et al., 1984), Hirschsprung disease (with the usual type I criteria) 
and myelomeningocele (Carezani-Gavin et al., 1992). Like the other WS 
characteristics, these anomalies are variable in expressivity and manifest in some 
affected individuals in a family and not in others. Omenn and McKusick (1979) 
reported 4 instances of Hirschsprung mega.colon in patients with WS. The overall 
population frequency of Hirschsprung disease is 2 in 10 000, while that of WS is 
approximately 2 in 100 000 and it can therefore be infered that the risk of joint 
occurrence of these syndromes would be 4 in a billion people. The reports by 
Omenn and McKusick (1979) alone exceed this frequency and indicate that there is 
some significance in this association. 
1.3. MOLECULAR BACKGROU1\1D 
1.3.1. The search for the WS locus 
WS is a typical example of the application of reverse genetics, where the gene and 
its location have been identified without prior knowledge of the gene product. This 
strategy involves associating the mutant locus with a chromosome map position and 
localising this position by intensive genome analysis. The identification of 
chromosomal rearrangements expedites the , mapping of the mutant locus, while 
homologies with the mouse genome facilitate in the fine mapping and cloning of the 
mutant gene. 
Loose linkage was proposed by Simpson et al. (1974) between WS I and the ABO 
blood group loci at 9p34. Arias and Mota (1978) could not confirm this linkage 
and the locus was excluded by Foy et al. (1990). A Japanese child with a de nova 
inversion (2)(q35-q37.3) and WS I was reported by Ishikiryama et al. (1989). The 
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child presented with heterochromia irides, leukoderma, deafness and dystopia 
canthorum. As no other abnormalities were noted, it was assumed that the 
inversion was cytogenetically balanced. This report suggested that the inversion 
inactivated the gene for WS I and implied that the gene was situated at either of the 
breakpoints: 2q35 or 2q37.3. lshkiriyama et al. (1993) later confirmed the location 
of the gene at 2q35. 
After the report of the chromosome 2 inversion (lshikiriyama et al., 1989), Foy et 
al. (1990) applied a marker, ALP-1 for alkaline phosphatase gene, at 2q37 for 
linkage analysis in families with WS I. Close linkage was demonstrated in 5 
informative families, with the peak lod score being 4. 76 at a recombination fraction 
of 0.023. The probability of this being a false positive lod score is lowered because 
the marker was not chosen randomly. The first reason for 2q being a candidate is 
that the breakpoints for the inversion described by lshikiriyama are at this location. 
The second, is the similarity of the WS I phenotype to the Splotch mouse. The 
region containing the Splotch locus on mouse chromosome 1 is highly conserved 
with its human counterpart on 2q. The cloning of the gene, which is the eventual 
aim of a reverse genetic strategy, is made a great deal easier by the availability of a 
possible animal model. Linkage of WS I to 2q was confirmed by Asher and 
Friedman (1991) with multipoint linkage analysis of RFLP's; 5 markers producing 
a peak lod score of 6.67. 
1.3.2. Identification of the gene using the Splotch mouse animal model. 
The Splotch (Sp) mouse was proposed as a model for WS I by Asher and Friedman 
(1990). Sp mouse mutants exhibit abnormalities of the neural tube and neural crest 
during development. Sp alleles are autosomal dominant/semidominant mutants with 
varying degrees of severity. Sp and Spd arose spontaneously and have the mildest 
phenotypes; both give rise to incomplete closure of the neural tube in the 
homozygous form. Heterozygotes have characteristic white belly spots. Sp', from 
X-ray irradiation, is the most severe form of the mutation. Homozygotes die before 
implantation and heterozygotes have white spotting of the belly and growth 
retardation. 
Sp' has a cytogenetically detectable deletion on mouse chromosome 1. Molecular 
analysis of the region was carried out to determine the subchromosomal location of 
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the deletion . The proposed gene order on chromosome 1 is Len2-Fn-Tpl-Vil-Des-
lnha-Akp3-Acrg-Sag. Epstein et al . (1991a) found that Vil, Des, Inha and A/...p3 
were deleted in the Sp' mutant. As Foy et al. (1990) had demonstrated linkage 
between WS I and the placental alkaline phosphatase locus on human chromosome 
2q, the results of Epstein et al. (1991a), which included the alkaline phophatase 
(Akp3) gene in the Sp' deletion, further implied that Splotch was the mouse model 
for WS I. 
Goulding et al. (1991) mapped an embryonically expressed gene, Pax 3, to mouse 
chromosome 1 in the region of the Splotch locus. The structure of Pax 3 identifies 
it as a member of a group of developmental control genes. These genes contain the 
conserved protein motifs: the paired domain, homeodomain and octapeptide, which 
indicate that they are involved in DNA binding. Comparison of the conserved 
genes of the paired box group shows that Pax 3 is most homologous to the human 
gene, HuP2, with identical paired box and octapeptide domains. This observation 
indicates that Pax 3 is the murine homologue of the HuP2 gene. 
r Sp I+ +/+ 
:J l 1 I ul.,· ,.,., 1>-• u 
V.0.- u .. 
u 
,,,_~ 
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A.Ip,$ u 
.., z..a 
I 
Figure 1.2. Chromosomal mapping of Pax 3 on mouse chromosome 1. 
Intergene distances (cM) are marked indicated to the right of the wild type 
chromosome and the deleted segment in the Spr/ + heterozygote is shown to the 
left (Taken from Epstein et al., 1991b). 
Using the Sp' mutant as before, Epstein et al. (1991b) mapped the position of Pax 3 
with respect to the other loci assigned to this region of chromosome I. The Pax 3 
gene was localised between lnha and Akp3 as shown in Figure 1. 2, confirming the 
tight linkage between Splotch and Pax 3. 
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Epstein et al. (1991b) examined the Pax 3 gene in another Splotch mutant, Sp2H, to 
investigate whether it was modified in any way. By Southern blot analysis it was 
determined that this mutant had an alteration in the Pax 3 gene. Sequencing 
confirmed a 32 base pair deletion in the Pax 3 homeodomain, interrupting the 
reading frame and creating a premature termination site. With the similarities in 
phenotype and the homologous map positions of Splotch and WS I, WS I was 
inferred to be the human homologue of the Sp mutant. Following this hypothesis, 
the human homologue of the Pax 3 gene causing Splotch in mice, would be the gene 
causing WS I in humans, namely HuP2. 
1.3.3. Mutations _in the HuP2 gene cause WS I 
Mutations were identified in the HuP2 gene by screemng the coding exons 
(Tassabehji et al., 1992; Baldwin et al., 1992). Three exons had been identified 
and designated exons 2, 3 and 4, because of their homology to these exons in the 
mouse Pax 3 gene. Primers were designed in the flanking introns for amplification 
of the exon sequences. Tassabehji et al. (1992) used heteroduplex analysis to test 
17 unrelated WS individuals and found 6 to have alterations; 3 patients with 
variations in exon 2, 2 in exon 3 and 1 in exon 4. Three of these mutations were 
extended to include all family members. Mutant alleles from exon 2 of one of the 
families were cloned and sequenced and revealed an 18 bp deletion in the paired 
box region of HuP2. The translational reading frame remains unaltered, however, 
the loss of 6 amino acids in such a conserved region of the gene would probably 
cause a loss of protein function. Balwin et al. (1992) used the method of single 
stranded conformational polymorphism to identify the mutation in a large Brazilian 
kindred. A single base substitution, modifying the codon for proline to that for 
leucine, caused WS in this family. The mutation occurs in a hydrophobic region 
just upstream from the paired domain and is thought to influence the specificity of 
DNA binding in the protein. Other mutations have been described in WS type I 
families and, together with the methods for mutation analysis, are discussed in 
Chapter 3. 
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1.4. PAX 3 IN EMBYROGENESIS 
Pax 3 is a member of a group of genes that regulate embryonic development. This 
family of homeobox containing genes is highly conserved from yeast to human, and 
control embryogenesis both temporally and spatially to ensure a highly ordered 
sequence of events imperative for normal development (Thorogood and Ferretti, 
1992). Although Waardenburg and Splotch present a complex phenotype, this is to 
be expected since Pax 3 is expressed early in embryogenesis and may regulate a 
number of diverse genes. 
Sensorineural deafness is the most serious of the characteristics defining WS. It is 
necessary, therefore, to understand the development of the inner ear and the 
concurrent events during embryogenesis. 
1.4.1. The development of the inner ear 
The inner ear begins as the otic placode, a thickening of the ectoderm, which 
appears at approximately three weeks after conception. This tissue invaginates to 
form the otic pit which grows downwards into the mesoderm (Figure 1.3). The 
surface ectoderm then closes to form the otic vesicle (or otocyst) . 
Ot ic vesicle 
Figure 1.3. The development of the otic vesicle. (Taken from Beighton and 
Sellars, 1982) 
The otic vesicle develops into two structures, the vestibular and cochlear parts. At 
six weeks the vestibular portion forms two pouches, which differentiate into the two 
vertical semicircular canals and the lateral canal. By nine weeks the vestibular 
component is well established, although the cochlear system is still undeveloped. 
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The cochlea grows from the sacculus as a spiral tube, completing two and a half 
turns by twelve weeks. A membranous labyrinth forms that separates the cochlea 
canal into three fluid-containing compartments: the scala vestibular, the scala media 
and the scala tympani. The epithelium of the cochlear duct differentiates into the 
tectoral membrane and the outer hair cells, while the organ of Corti begins to 
develop. The outer wall epithelium becomes glandular and underlying connective 
tissue undergoes vascularisation giving rise to the stria vascularis. The inner ear is 
fully formed twenty five weeks after conception. 
As analysis of genes controlling development of the ear is not practical in humans 
and audiometric tests reflect only the type and severity of the hearing defect, it is a 
great advantage to acquire an animal model. This provides an ideal genetic 
background for studying normal development and the effects of individual gene 
mutations that may be involved in the pathogenesis of genetic deafness. 
The mouse has provided a fitting model for analysing gene expression during 
development and many mouse mutants have been described with defects involving 
the ear. The inner ear of mice and humans is very similar , differing only in size, 
amount of bone surrounding the labyrinth and number of rows of hair cells (Steel, 
1991). 
Early investigation by Deol (1966) has shown that different iation of the otic vesicle 
into a normal labyrinth depends on the influence of the neural tube. Two mouse 
mutants were studied, Loop tail (Lp) and Splotch (Sp), both having abnormalities of 
the neural tube. Homozygotes in these mutants die during middle of late gestation. 
Embryos of 10-13 days were examined and compared. In both mutants the neural 
tube is believed to be the site of gene action and the inner ear anomalies are 
secondary effects of the genes concerned. 
1.4.2. Pax 3 expression during embryogenesis 
Goulding et al. ( 1991) studied the expression of Pax 3 in the developing mouse 
embryo. By Northern blot analysis it was shown that Pax 3 transcripts were only 
present from 9 -17 days post coirum. Detectable levels of Pax 3 were not present in 
adult tissues , indicating a specific temporal expression. 
The spatial distribution of expression in the developing mouse embryo was analysed 
by in siru hybridisation. The first transcripts were detected in the dorsal region of 
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the neural groove and in the neural tube. As the neural tube closes from the rostral 
to the caudal region, Pax 3 expression moves from the neural groove to the dorsal 
neural tube and dorso-lateral somites, indicating · a regulated temporal difference of 
expression in the posterior part of the embryo. 
A multipotential population of cells, the neural crest, develops from the dorsal 
neural tube and migrates laterally to specific positions where the cells differentiate. 
(Figure 1.4.) 
Figure 1.4. Migration of the neural crest cells (NC) from the neural tube of the 
segmented hindbrain into the forming branchial arches (B2, B3). The 
transected surface is marked with an asterisk. OV, otic vesicle; Et ectoderm 
covering dorsolateral surface of embryo; r4,r5,r6 rhombomere segmentations; 
gVII/VIII/IX are the cranial ganglia. (Taken from Thorogood and Ferretti, 
1991) 
Transplantation studies have shown that the invagination of the otic placode and the 
development of the otic vesicle are dependent on the close proximity of 
rhombomeres 5 and 6. The early morphogenesis of the vestibular and cochlea 
components is able to progress; spatial arrangement of these systems, however, 
requires the continued presence of the periotic mesychyme arising from the neural 
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crest (Noden and Van der Water, 1992). The neural crest is also fundamental in the 
formation of the middle ear ossicles and the outer ear as well as the positioning of 
the Eustachian tube and the tympanic membrane. 
As well as being crucial to the formation of the ear, the neural crest contributes to 
most facial tissues, cranial ganglia, autonomic system ganglia, aortic arch arteries, 
pigment cells and other tissues. The phenotypic characteristics of WS can, 
therefore, be explained by a disruption in the migration of neural crest. The 
depigmentation in WS is due to a lack or absence of melanocytes in these areas 
(Ortonne, 1988), not the inability of the melanocytes to produce melanin. This 
indicates a deficiency in the ability of the melanoblasts to migrate to these regions. 
The occasional association of Hirschsprung disease and heart anomalies with WS 
may be explained by the failure of neural crest cell derivatives to uniformly 
populate the respective organs involved in these conditions. Kaplan · and de 
Chaderevian (1988) reported a patient with deafness, patchy leukoderma, 
heterochromia irides, Hirschprung disease and pulmonary artery stenosis. Bowel 
biopsy analysis showed that ganglion cells were not absent from the bowel, but 
were abnormally distributed, as well as colonising regions usually devoid of 
ganglions. This is in contrast to the pathology of Hirschpnmg disease, where there 
is a completely aganglionic zone. Similarly tissue from the skin displayed abnormal 
distribution of melanocytes, which suggests disorderly migration of the neural crest. 
Steel and Barkaway ( 1989) suggested another role for migratory melanocytes in the 
inner ear. They demonstrated that melanocyte-like cells in the stria vascularis were 
vital for the normal development of the stria and the production of an endocochlear 
potential (EP). In the viable dominant spotting mouse mutant, known to have a 
neural crest defect, there was an apparent absence of melanocytes in the stria as well 
as ultrastructural anomalies, which impaired the production of an EP by the stria. 
This observation could explain why mammals with spotting mutations often have 
associated deafness. 
The expression of Pax 3 is concurrent with the production and migration of the 
neural crest, initiating at the dorsal part of the neural tube and moving laterally. 
The homeodomain and the paired box sequence indicate that the Pax 3 protein is 
involved in DNA binding, modulating transcription. The genes which it regulates 
are thus far unidentified. 
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CHAPTER2 
WAARDENBURGSYNDROMEIN 
SOUTHERN AFRICA 
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CHAYfER 2. WAARDENBURG SYNDROME IN SOUTHERN 
AFRICA 
2.1. INTRODUCTION 
Since 1975 the departments of Human Genetics and Otolaryngology (University of 
Cape Town and Groote Schuur Hospital) have undertaken diagnostic surveys in an 
attempt to identify the cause of deafness in children attending special schools for 
hearing-impaired scholars in Southern Africa (Sellars et al., 1975; Sellars et al., 
1976; Sellars et al., 1977; Sellars and Beighton, 1978; Sellars and Beighton, 1983a, 
1983b; Beighton et al., 1987; Viljoen et al., 1988). Accurate diagnosis of the 
disorder underlying the deafness in these children is vitally important for prognosis 
and optimal management and, in the event of inherited deafness, for genetic 
counselling. 
Of the 4452 scholars who were examined, a specific genetic syndrome could be 
diagnosed in 8% (Beighton et al., 1991). Waardenburg syndrome was found to be 
the most common form of congenital syndromic deafness manifesting in 2.7% of 
the total number of students. Although ethnic variation in prevalence was found, 
WS was present in children from all communities. 
The families of several children attending special schools were investigated in order 
to provide the pedigree data and biological material which formed the subject of this 
study. 
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2.2. IDENTIFICATION OF SUBJECTS 
The probands in this study were identified during aetiological surveys in special 
schools for the deaf and routine clinics by the departments of Human Genetics and 
Otorhinolaryngology. Each patient was examined clinically and assessed 
genealogically and, where appropriate, family members were visited and examined 
for WS. A positive diagnosis was made using the standard diagnostic criteria 
(Farrer et al., 1992; Winship and Beighton, 1992) as shown in Table 2.1. These 
criteria were identified and accepted by the Waardenburg Consortium (Farrer et al., 
1992) for a collaborative study, in order to minimize misclassification of subjects. 
As part of the Consort~um, the Southern African families were evaluated according 
to these guidelines. 
For an unequivocal diagnosis an affected individual must have at least two major 
characteristics of WS or have one of the major criteria and two of the minor 
criteria. Rare associations were not used in establishing a diagnosis. 
Many of the WS affected children attending special schools for the deaf and their 
families were re-examined by Winship and Beighton (1992), with strict attention 
paid to phenotypic characteristics. Measurements of periorbital structures were also 
taken at this time. The WARD index was calculated (Chapter 1, 1.2.2.) for the 
objective evaluation of dystopia canthorum in order to differentiate between WS 
type I and type II. 
Blood samples were collected, with informed consent, in EDTA anticoagulant 
tubes. The blood was separated into 10 ml aliquots and DNA was extracted using 
the Biotest method (Biotest Diagnostics) or frozen at -70°C for later processing. 
24 
Table 2.1. Diagnostic criteria for WS 
Major: 
1. Sensorineural deafness. 
2. Iris pigmentary abnormality: 
a. Two eyes of different colour 
b. Iris bicolour/segmental heterochromia 
c. Characteristic sapphire blue irides 
3. Hair hypopigmentation 
a. White forelock 
b. White body hair 
4. Dystopia canthorum * 
5. First degree relative previously diagnosed with WS 
Minor: 
1. Congenital leukoderma 
2. Synophrys 
3. Broad nasal root 
4. Hypoplasia of alae nasi 
5. Premature greying of hair 
Rare: 
1. Hirschprung disease 
2. Sprengel anomaly 
3. Spina bifida 
4. Cleft lip/palate 
5. Limb defectl 
6. Congenital heart anomalies 
7. Abnormalities of vestibular function 
8. Broad square jaw 
9. Low anterior hair line. 
* Indicates WS type I 
# Found in WS type III 
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2.3. RESULTS OF CLINICAL ANALYSIS 
Ten families with WS were clinically assessed and consented to DNA studies. In 
total, 146 individuals agreed to provide blood specimens by venipuncture; of these 
persons, 72 were affected with WS. The pedigrees of the families are illustrated in 
Figure 2.1. WSl 
II 
Ill 
IV 
V 
• • • WS2 • • • • * •• * 
I 
II 
Ill 
• 
IV 
• • • • • • • 
WS3 WS4 
I I 
II II 
• • • 
Ill Ill 
• • • 
• • • 
IV • • 
Figure 2.1. The pedigrees of the WS families in this study. CJ = male, O = 
female,• affected male,e affected female. An asterisk marks the individuals 
from whom blood was taken. 
• 
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WS5 WS6 
II • II 
* • 
III m 
* • • • • • 
WS1S 
WS27 
I 
I 
II 
II 
m 
• • 
m 
• 
WS41 N' 
• • • • 
I 
~1 -0 • I 66 • 6 • II • :a;. * * • * • * * 
WS48 
I 
II 
m ;r.~~. 
IV 
• • • • * • 
V 
* 
Figure 2.1. The pedigrees of the WS families in this study. O = male, 0 = 
female, a affected male,• affected female. An asterisk marks the individuals 
from whom blood was taken. 
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The characteristic stigmata of WS were present in these families with intrafamilial 
variability in their expression. The major features are depicted in Figures 2.2. - 2.5. 
A description of the phenotypic manifestations of the affected individuals in each 
family is presented in Table 2.2. A further 37 affected individuals , with no family 
history of WS or whose family history was unavailable, were also examined and 
agreed to take part in the molecular investigation. 
Figure 2.2. WS in a girl with profound perceptive deafness, heterochromia 
irides, synophrys and dystopia canthorum. (With permission, Beighton and 
Sellars, 1983). 
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Figure 2.3. Dystopia canthorum together with a white forelock, depigmentation 
of the medial portion of the eyebrows and patchy leukoderma. With 
permission, Beighton and Sellars, 1983). 
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, 
, 
l 
Figure 2.4. Intrafamilial variability of the WS phenotype (pedigree WS 2). 
(With permission, Winship and Beighton, 1992) 
Figure 2.5. Pa11ial heterochromia and unusual skin depigmentation in a 
profoundly deaf boy. Dystopia canthorum is absent. 
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From the table it is evident that 7 of the families can be designated as WS type I, 
while 3 kindreds were in the type II category f'NS 6, 27 and 41). Where 
measurements were taken, the WARD index was calculated and it is noteworthy that 
subjective assessment was consistently in keeping with these indices. With the 
exception of one family member in WS family 15 (Il-5), all affected individuals 
within the type I WS families had dystopia canthorum. The range of the WARD 
index in each family is shown in Figure 2.6. 
WARD index 
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Figure 2.6. The range and mean values of WARD indices of affected 
individuals from each of the families. 
Some persons with sporadic WS proved difficult to classify into type I and type II. 
In conjunction with the WARD index, 15 individuals could be distinguished as 
having WS type I and 13 as having WS type II. The categorisation of the remaining 
9 persons was equivocal. 
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2.4. DISCUSSION OF CLINICAL ANALYSIS 
With one exception, the pedigrees of the families with WS showed an autosomal 
dominant pattern of inheritance. In Family 6, however, the parents in generation I 
were clinically normal and none of the affected persons had produced offspring with 
the condition. This inheritance pattern could be explained by non-penetrance or 
autosomal recessive inheritance. Autosomal recessive inheritance is, however, not a 
recognised mode of transmission of WS and therefore it is unlikely. Another 
explanation could be that of germ-line mosaicism in one of the parents. This would 
account for the number of affected siblings in generation II. Germ-line mosaicism 
has previously been reported in WS by Kapur and Karam (1991). 
The families with WS I conformed to the expected percentage of affected members 
with hearing impairment (10 out of 53) at 19%. Disparate figures were obtained 
for the type II families, with a high frequency of deafness at 88 % ; the accepted 
figure being only 50%. 
lntrafamilial phenotypic variation was present as expected , with the exception of 
two of the type II families. The manifestations of WS in families 6 and 41 were 
strikingly uniform: all four affected siblings of WS family 6 had sapphire-blue eyes, 
white forelock, patchy depigmentation of the skin of the wrists and fore arms and 
profound deafness; all affected members of WS family 41 displayed unusual 
pigmentary changes in the skin, profound deafness and abnormalities of iris colour. 
Rare associations with WS were encountered in only one family, WS 48. 
Hirschprung disease was present in two family members (III-4, IV-3) and a bilateral 
cleft palate in another. A small branch of this family had consistent heterochromia, 
with the right eye blue, and unilateral deafness on the right side. No correlation 
between heterochromia and deafness could be made in the rest of the family. 
The WARD 1ndex was used to distinguish between families with WS type I and type 
II. Interocular distances, however, vary in affected and unaffected individuals and 
ethnic variation is also of importance. For this reason, it has been suggested that it 
is advisable to note the trend of the indices of affected relatives , rather than to 
assess only one individual (Farrer et al. , In press). All type I families in the 
Southern African study had a mean WARD index ~ 2.00 , whereas the type II mean 
was :5; 1. 76. One member of WS family 15 seemed non-penetrant for all stigmata 
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of WS , as her father and two sons were clearly affected . When her index was 
excluded from the mean in this family, the average rose from 1.94 to 2.00. This 
change in the average is not significant, however it is prudent to exclude the W 
index of the non-penetrant individual from the calculation of the mean in this 
family. 
Unequivocal diagnosis and the differentiation between WS type I and type II are not 
only important for genetic counselling, but also vital for the strategy appropriate for 
molecular testing and the analysis of the results. 
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CHAPTER3 
LINKAGE ANALYSIS 
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CHAPTER 3. LINKAGE ANALYSIS 
3.1. INTRODUCTION 
A gene for Waardenburg syndrome was localised to chromosome 2q37 by Foy et al. 
(1990), who obtained close linkage to the placental alkaline phosphatase (ALPP) 
locus at this position. The probe ALP-1 was used to detect an Rsa I polymorphism 
which, in five informative families, gave a combined lod score maximizing at 4. 767 
at a recombination fraction of 0.023. Four RFLP markers on 2q, including ALP-I, 
were used in a five-point linkage analysis by Asher et al. (1991) . This analysis 
established significant linkage in a single WS I family, with a lod score of 6. 667. 
By pooling the linkage results of 44 WS kindreds from different countries, the WS 
Consortium refined the location of the WS on 2q (Farrer et al ., 1992). This 
collaborative study revealed that there was genetic heterogeneity in WS, with only 
45 % of all the families in the sample linked to the locus on 2q. The paired box 
gene, HuP2 (now known as PAX3) at 2q35-37, was implicated in causing WS I 
when pathogenic mutations were identified in kindreds with this form of the 
disorder (Tassabehji et al., 1992; Baldwin et al., 1992). 
To establish which of the South African families were linked to PAX3, linkage 
analysis was performed using microsatellite markers flanking the PAX3 gene (Farrer 
et al., In press) The CA repeat markers that were selected have a higher 
polymorphism information content (PIC) than the RFLP-based systems used 
previously, as well as being in close proximity to the PAX3 gene. Families that 
were unlinked to PAX3 did not warrant mutation screening of this gene. 
Those families that were not linked to PAX3 were tested with other polymorphic 
markers surrounding three possible candidate loci that had not previously been 
reported. Markers on lOq were analysed because an interstitial deletion (10ql 1.2-
q22.1) had been described in a boy with bright blue irides and other congenital 
abnormalities (Zenger-Hain et al. , 1993). Furthermore, this region is close to the 
RET gene which, in the mouse, maps close to the microphthalmia (mi) locus. The 
mi mouse mutant was suggested to be a model for WS on the basis of phenotypic 
similarity. (Asher and Friedman, 1990) . 
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The human homologue of the mouse mi gene, MITF, was mapped to 3p12.3-pl4.1 
(Tachibana et al., 1994). Hughes et al. (1994) established linkage of two WS type II 
families to markers on chromosome 3 in the region of the MITF gene. Markers at 
this locus, therefore, were also included in the linkage analysis of the WS type II 
families in this study. 
A report of a chromosomal translocation t(7;20)(q22.1-q13.13) in a male infant 
with WS type II (Hood et al., 1989) led to the investigation of markers at the 
breakpoints of the translocation on chromosomes 7 and 20. 
3.2. METHODS 
Genotypes were interpreted from the allele amplification of highly polymorphic CA 
repeat polymorphisms in the region under investigation. PCR amplification of the 
CA repeat fragments was carried out in 25 µl volume reactions containing: 25 pmol 
of each primer, 200 ng DNA, 200 µM dNTP's (Boehringer Mannheim), 1 unit Taq 
polymerase (BRL) and 1 µCi o:-32p dCTP (Amersham) in a 1 x reaction buffer. 
Most of the reactions were optimized using the 10 x standard reaction buffer 
containing 500 mM KCl, 100 mM Tris (pH 8.4) and 15 mM MgCl2. Some 
primers required the addition of 0.01 % gelatin, 0.1 % triton or 0.4 % 6-
mercaptoethanol. An overlay of liquid paraffin was added to each sample to 
prevent evaporation during the reaction. Each PCR reaction was subjected to thirty 
cycles of amplification in a thermalcycler (Hybaid Omnigene). 
Three microlitres of formamide loading dye (80% formamide, 10 mM EDTA, 
0.02% bromophenol blue and 0.02 % xylene cyanol) was added to 2 µl of the 
amplified product and denatured on a heating block at 97°C for 3 min. The 
samples were placed on ice before loading on 6 % polyacrylamide gels, containing 
5.7 % acrylamide, 0.3 % bisacrylamide, 7.65 M urea and l x TBE (0.089 M Tris, 
0.089 M Boric acid, 0.002 M EDTA). The gels were electrophoresed at 60 Watts 
in a 1 x TBE running buffer, using the marker dyes in the loading dye to determine 
at which point the repeat fragments would be fully resolved. The gel was 
transferred ?nto Whatmann 3MM paper and dried on a Hoeffer Slab Gel Dryer at 
80°C for 1 hour. Overnight exposure of the dried gel to an X-ray film (Agfa 
Curix) occured at -70°C. The X-ray film was developed in Cronex developer and 
fix solutions (Protea) and the genotypes ascertained. 
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The markers and PCR conditions used for linkage analysis in the region of the 
PAXJ gene are set out in Table 3.1. 
Table 3.1. Microsatellite markers used for linkage analysis on chromosome 2 
Marker Location No. of PIC 
alleles 
D2S102 2q 11 .87 
D2S211 2q34-q37 8 .70 
PAX3 2q35-q37 9 .80 
PCR 
conditions 
94°c 30" 
54°c 30" 
n °c 30" 
94°c 1' 
so 0 c 1' 
72°c 1' 
94°c l' 
55 °c 1' 
72°c 1' 
References 
Genome Data 
base 
Barber et al. ' 
1993 
Wilcox et al.' 
1992, Morrell 
personal 
communication 
The markers that were used for linkage to loci other than PAX3 are presented in 
Table 3.2. 
Table 3.2. Markers used for linkage analysis in families that were not linked to 
PAX3 
Marker Location PIC Source 
Dl0S199 lOqll 0.84 Genethon 
D10S220 lOql 1 0.83 Genethon 
D7S479 7q21.3-q22 0.83 Research Genetics 
D7S501 7q31 0.81 Research Genetics 
PLCl 20q12-ql3.1 Research Genetics 
RPN2 20q12-ql3. l Research Genetics 
D20S25 20q13 Research Genetics 
D20S17 20q Research Genetics 
D20S120 20q 0.85 Research Genetics 
D20S102 20q13-ter 0.64 Research Genetics 
D20S52 20q Research Genetics 
D3S1217 3p14 Hughes et al. ' 1994 
D3S1 2 10 3p13 Hughes et al.' 1994 
D3S1284 3p13-pl4 0.74 Hughes et al .' 1994 
D3Sl 285 3p14 0.72 Hughes et al. ' 1994 
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The PCR conditions were optimised for each marker individually and the reactions 
carried out as described for the chromosome 2 markers. The majority of markers 
functioned optimally at the cycling conditions of: 94 °C for 1 ', 56°C for 1' and 
72°C for 2'. D20S25, however, required an annealing temperature of 60°C. 
Two point linkage analysis was performed using the MUNK Ver. 5.03 package 
(Lathrop and Lalouel, 1984). The lod scores between the markers and the WS loci 
were calculated using recombination fractions from 0.00 to 0.40. The penetrance 
was set at 93% with a gene frequency of 0.0001. 
3.3. ANALYSIS OF LINKAGE 
The results of the linkage analysis between the WS phenotype and markers on 
chromosome 2 are shown in Table 3. 3. Two families (WS 1 and WS 48) were 
clearly linked to PAXJ, with lod scores of 7.76 and 3.37, repectively, at 8 = 0.00. 
A lod score of 1.0 or greater, maximising at 8 = 0.00, was considered enough to 
indicate possible linkage in WS families 2, 4 and 5. In WS 4, PAX3 was 
uniformative due to the homozygosity of the alleles in an affected matriarch (II-2 on 
pedigree) and therefore D2S211 is a better indication of the probability of linkage. 
A low positive lod score was obtained at 8 = 0.00 in 2 families (WS 3 and WS 
15). These families could not be excluded from being linked to PAX3. On visual 
examination of the genotypes in WS 3 and WS 15 no obvious recombinants were 
observed between the WS phenotype and the marker PAX3. The lod scores 
obtained, therefore, were due to the small number of meioses in each of these 
families. In WS 6 one recombinant was observed; the lod score peaked at 8 = 
0.10 for the marker PAX3 and at 8 = 0.05 for the other two markers. In the 2 
remaining families, lod scores of less than -2.00, the accepted value for significant 
exclusion (Lester et al., 1990), at 8 = 0.00, indicated that these families were not 
linked to P AX3. 
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Table 3.3. Pairwise lod scores between WS and markers in the region of PAX3. 
Family Locus Recombination fraction (8) 
0.00 0.05 0.1 0.2 0.3 0.4 
ws 1 PAX3 7.76 7.10 6.41 4.93 3.30 1.54 
WS2 PAX3 1.15 1.05 0.94 0.72 0.48 0.24 
D2S102 1.20 1.24 1.20 0.99 0.67 0.29 
D2S211 -3.3 0.22 0.46 0.53 0.39 0.19 
WS3 PAX3 0.57 0.51 0.44 0.30 0.16 0.05 
D2S102 0.57 0.51 0.44 0.30 0.16 0.05 
D2S211 0.30 0.26 0.21 0.13 0.06 0.02 
WS4 PAX3 0.46 0.38 0.31 0.18 0.08 0.02 
D2SI02 0.38 0.33 0.29 0.22 0. 14 0.05 
D2S2I 1 1.28 1.12 0.96 0.64 0.33 0.09 
WS5 PAX3 1.17 1.06 0.95 0.70 0.43 0.17 
D2S102 0.69 0.61 0.52 0.34 0.18 0.06 
D2S211 0.87 0.76 0.65 0.41 0.19 0.04 
WS6 PAX3 0.30 0.40 0.42 0.37 0.23 0.08 
D2S102 0.84 0.89 0.85 0.66 0.38 0.11 
D2S211 1.11 1.14 1.08 0.84 0.50 0.16 
ws 15 PAX3 0.04 0.04 0.03 0.03 0.02 0.01 
D2Sl02 0.30 0.28 0.26 0.20 0.15 0.08 
ws 27 PAX3 -6.04 -2.18 -1.57 -0.88 -0.47 -0.19 
D2S102 -5.95 -1.65 -0.99 -0.36 -0.08 0.02 
D2S211 • -5.0 -1.18 -0.64 -0.17 -0.01 -0.01 
ws 41 PAX3 -6.30 -1.24 -0.72 -0. 28 -0.1 0 -0 .02 
ws 48 PAX3 3.97 3.62 3.26 2.52 1. 74 0.90 
The families that were unlinked at the PAXJ locus were analysed for linkage using 
markers at other possible candidate loci. The resulting lod scores are presented in 
Table 3.4. 
Table 3.4. Linkage analysis of families that were not linked to PAX3 
Family Marker Recombination fraction (8) 
0.00 0.05 0.10 0.20 0.30 0.40 
WS6 D7S479 -5.67 -1. IO -0.63 -0.23 -0.08 -0.02 
D7S501 -6.24 -1.39 -0.86 -0.35 -0.13 .-0.03 
PLCl -8.05 -1.39 -0.77 -0.26 -0.07 -0.01 
RPN2 -0.96 -0.67 -0.44 -0.17 -0.05 -0.01 
D20S17 -0.02 -0.04 -0.06 -0.09 -0.07 -0.03 
D3S12IO -4.48 -1.36 -0.74 -0.22 -0.05 -0.00 
D3S1217 -1.05 -0.73 -0.49 -0.20 -0.06 -0.01 
ws 27 D7S479 -4.85 -0.29 -0.05 0.12 0.14 0.08 
D7S501 -4.63 -1.84 -1.21 -0.62 -0.31 -0.12 
DI0S199 -8.66 -1. 78 -1.02 -0.40 -0.15 -0.03 
D10S220 0.18 0.19 0.18 0.13 0.06 0.01 
PLCl -6.76 -2.22 -1.38 -0.53 -0.14 0.02 
RPN2 -6.85 -1.50 -0.79 -0.17 0.04 0.07 
D20S17 1.56 1.41 1.25 0.93 0.58 0.25 
D20S52 1.56 1.56 1.47 1.17 0.76 0.34 
D20S102 0.72 0.60 0.50 0.32 0.14 0.02 
D20S25 -3.13 0.55 0.76 0.74 0.48 0.14 
D3S1210 -4.05 -2.22 -1.60 -0.83 -0.37 -0.11 
D3S1217 -0.51 -0.24 -0.10 0.02 0.04 0.02 
ws 41 D3S1217 1.81 1.65 1.49 1.13 0.72 0.28 
D3Sl284 1.81 1.65 1.49 1.13 0.72 0.28 
As linkage had already been established to a locus on chromosome 3 in WS type II 
families (Hughes et al., 1994), a lod score of 1.81 is indicative of possible linkage 
in WS family 41. The markers are fully informative for linkage in this family as 
depicted by the genotypes shown on the pedigree illustrated in Figure 3.1. 
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Markers Alleles 
D3Sl2l7 1, 2, 3, 4, 5 
D3Sl284 1, 2, 3, 4 
D3Sl285 1, 2, 3 
I 
* * 
2 3 3 1 
1 3 2 4 
3 3 1 2 
II • • 
* * * * 
* 
* * 
3 1 3 3 3 3 2 1 2 3 3 3 3 
3 4 3 4 3 2 1 4 1 2 3 2 3 4 
3 2 3 1 3 1 3 2 3 1 3 1 3 2 
Figure 3.1. Pedigree of WS family 41 showing the genotypes of markers on 
chromosome 3.0 = male, O = female,•= affected male,•= affected female. 
The combination of genotypes of the markers analysed on chromosome 20 is 
illustrated on the pedigree shown in Figure 3.2. Haplotype analysis shows possible 
linkage of WS type II and this region on chromosome 20 in this family. 
45 
I 
II 
* •· * * 
6 4 2 4 2 3 2 3 
4 I s I s s s s 
2 3 2 3 2 4 2 4 
4 4 s 3 s 3 s 3 
6 2 2 7 2 7 6 7 
2 3 2 3 2 2 2 
3 4 s 4 s 3 s 
III 
* * * * * * 
4 4 s 3 s 2 s 2 s 2 
s s 2 2 s 4 s 4 s 4 s 
4 2 4 4 2 4 4 2 4 3 4 3 
3 s 7 7 6 3 s 3 3 3 3 
2 s 3 6 7 1 2 4 7 1 7 
2 3 2 3 3 3 3 3 3 2 3 2 
3 4 3 3 I 2 2 4 2 s 2 . s 
IV 
* 
. • * 
4 s 2 
5 2 2 s 
2 4 2 2 
5 7 s 
2 3 6 2 
3 3 3 3 
3 3 4 
Figure 3.2. The pedigree of WS 27 with genotypes for each of the markers 
analysed on chromosome 20 Shaded bars represent haplotypes of the 
genotypes. The genotypes under each individual are in the following order: 
RPN2, PLCl, D20S17, D20S120, D20S52, D20S102, D20S25 (Personal 
communication, S. M_arc, Genethon). 
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3.4. DISCUSSION OF LINKAGE ANALYSIS 
Seven of the Southern African families, WS 1 - 6 and WS 27, formed part of a 
linkage study carried out by the Waardenburg Consortium to determine the precise 
proportion of families linked to PAX3. One of the conclusions of this investigation 
was that WS type I families were linked to PAX3, whereas type II families were 
unlinked (Farrer et al., 1994). Linkage results of the SA families in this study that 
were not included in the Consortium study are in accordance with their findings. 
Of the seven WS type I families, five had adequate lod scores to be suggestive of 
linkage, while the remaining two were found to be equivocal. The SA WS type II 
families were found not to be linked to PAX3 and therefore, only the WS type I 
families need be screened for mutations in PAX3. Sporadic individuals with 
dystopia canthorum could not be subjected to linkage analysis. However, the 
conclusive evidence of the disorder in WS type I families being due to alterations in 
the PAXJ gene, warranted screening of sporadic WS I individuals for mutations 
within this gene. 
A lod score of 1.81 at 8 = 0.00 implied that WS family 4 1 may be linked to the 
type II locus on chromosome 3p. Because the family is small (9 members, 6 
affected) with all meioses fully informative at the marker locus, a higher lod score 
was not attainable. The 2 other WS type II families in this study were unlinked at 
this position , confirming the suggestion by Hughes et al. (1994) that WS type II is 
genetically heterogeneous. 
The disorder in family WS 27 may be linked to chromosome 20ql3 . This locus has 
been associated with WS II in the report of a chromosomal translocation involving 
this region (Hood et al., 1989). Pairwise lod scores are indicative of the probabilty 
of linkage and haplotype analysis strenghthens this proposal. Analysis of further 
markers in this region is required to confirm this hypothesis and to refine the 
position of the possible gene locus. 
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CHAPTER4 · 
MUTATION ANALYSIS 
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CHAYfER 4. MUTATION ANALYSIS 
4.1. INTRODUCTION 
4.1.1. The structure of the PAX3 gene 
The genes involved in the programming of early human development are thought to 
have evolved from primordial genes containing conserved protein domains. One of 
these genes, PAX3 (or HuP2) was first described by Burri et al. (1989). The PAX3 
gene contains the paired domain, which is a highly conserved protein motif found in 
organisms from Drosophila to man. The coding sequence of the paired domain in 
PAX3 was shown to be interrupted by two introns and contained an amphipathic a-
helix in the first exon, a helix-turn-helix structure in the second and a conserved 
octapeptide in the third (Figure 4.1.). Goulding et al. (1991) described a 
homologous mouse gene, with identical exon-intron boundaries and protein 
domains. The sequence of this mouse gene (Pax3) was extended at the 3' end to 
include a paired type homeodomain and thus, based on the close similarity, the 
human counterpart was predicted to also contain this protein domain. The exons 
sequenced by Burri et al. (1989) were therefore numbered 2, 3 and 4 in keeping 
with the predicted sequence from the mouse homologue. 
EXON 2 
66 bp 321 bp 
30 107 
EXON 3 
322 bp 451 bp 
106 151 
EXON 4 
452 bp 
152 
566 bp 
196 
H 
Figure 4.1. The structure of the paired domain of the PAX3 gene The shaded 
region represents the paired domain and octapeptide, with the helices and 
octapeptide indicated below. The numbers shown above refer to the position of 
the exons with regard to the nucleic acid sequence, while the numbers below 
ref er to the amino acid sequence. 
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Hoth et al. (1993) provided further sequence inform~tion and confirmed homology 
of the mouse and human gene structure at the 5' and 3' ends. Exon 1 proved to be 
small, while exon 5, contained the predicted homeodomain. In 1994 Tassabehji et 
al. determined, by systematic testing with multiple primers from the cDNA 
sequence, that three introns existed 3' of intron 4. The exon-intron boundaries were 
identified between exons 5, 6, 7 and 8. The homeodomain was split by intron 5 as 
illustrated in Figure 4.2. 
2 3 4 5 6 7 B 
1 bp 86 bp JZZ bp 45Z bp 587 bp 795 bp 956 bp 1174 bp 
D--[all---a=IJ--CII-
30 108 JSZ 197 Z65 3ZO 39Z 
Figure 4.2. The structure of the PAX3 gene with the 3' homeodomain. The 
shaded regions represent the paired domain, octapeptide and homeodomain. 
The numbers shown above ref er to the position of the exons with regard to the 
nucleic acid sequence, while the numbers below ref er to the amino acid 
sequence. 
The determination of the exon-intron boundaries and the flanking intronic sequences 
was vitally important for mutation analysis of the PAX3 gene in the pathogenesis of 
Waardenburg syndrome. Furthermore, the amino acid sequence predicted from the 
sequence of the DNA enabled the recognition of the functional domains of the 
proposed protein. Mutations, which do not lead to a truncated protein, may cause a 
loss of function as a result of their location in a functional domain. 
4.1.2. Mutations in PAX3 
PAXJ is expressed only during early human embryonic development making it 
impractical to analyse the protein or mRNA for alterations in size or structure in 
WS affected individuals. However, with the identification of the exon-intron 
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boundaries, the coding regions could be screened for mutations using genomic 
DNA. Amplified exons were screened by heteroduplex and single stranded 
conformational polymorphism (SSCP) analysis to identify the first mutations in 
PAX3 causing WS (Tassabehji et al., 1992; Baldwin et al. , 1992). SSCP analysis 
(Ori ta et al., 1989) is based on the differing mobility of single stranded DNA in a 
non-denaturing gel, as a result of its secondary structure or conformation. A 
mutation disrupting the secondary structure of a DNA fragment is clearly 
recognised by the difference in the banding pattern of the single strands. 
Heteroduplex analysis (White et al., 1992) involves the formation of heteroduplexes 
between normal and mutant alleles. The infidelity of binding retards the migration 
of the heteroduplex fragment on a non-denaturing gel. 
Tassabehji et al. (1992) cloned and sequenced the mutant allele in one family 
showing an 18 bp deletion. Although this was an in-frame deletion, the 6 codons 
deleted include the last 3 amino acid codons for the amphipathic a-helix in a highly 
conserved region of exon 2. 
Sequencing of the "SSCP" variant exon in a large affected Brazilian family showed 
a single-base substitution (Baldwin et al., 1992). The mutation occurred 17 amino 
acids (aa) into the paired domain, replacing a proline codon for a strongly 
hydrophobic leucine residue. This change may prevent DNA binding of the paired 
domain by altering the tertiary structure of the protein around the first a-helix. The 
·phenotype in the family is variable and the frequency of deafness is unusually high 
(78 %). 
The above in-frame mutations, although potentially pathogenic, leave most of the 
protein intact. A frameshift mutation, reported by Morrell et al. (1992), was 
caused by a deletion of 14 bp at the end of exon 2 in an Indonesian family with WS 
I. The shift in reading frame caused a premature termination codon 6 aa into exon 
3. The truncated protein would not include the rest of the paired domain and lack 
the entire homeodomain. The functional impairment of PAX3, as in the family 
reported by Baldwin et al. (1992), causes an unusually high penetrance (75 %) of 
sensorineural deafness in this type I family. WS mutations reported to date are 
listed in Table 4.1. 
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A wide variety of mutations in the PAXJ gene have been identified in WS I. A 
family with WS III was also found to have a single base substitution (See Table 4.1, 
family BU47) in the paired domain of PAX3 (Hoth et al., 1993). WS I shows 
intragenic heterogeneity, with no correlation between the genotype at the mutation 
level and the resulting phenotype. The South African families with WS have been 
screened in order to characterise the mutations existing in our local population. 
4.2. METHODS 
The PAX3 gene was divided into smaller regions for PCR amplification using the 
exon-intron boundaries to mark the divisions. Each set of PCR primers was 
designed to include the whole of the coding exon and a small part of each of the 
flanking introns. In this way small fragments, which together covered the most of 
the coding region of PAX3, could be amplified for mutation screening. 
Exons 2, 3 , 4, 5, 6 and 7 of PAX3 were amplified using 100 - 200 ng genomic 
DNA in 25 µl reactions, containing 12.5 - 25 pmol of each primer, 200 uM dNTPs 
(Boerringer Manheim), 1 unit Taq polymerase (Gibco BRL) and a standard 
amplification buffer (See section 3.2) in a DNA thermalcycler (Hybaid). The 
reaction mix was overlaid with liquid parafin to prevent evaporation. The reactions 
were optimised for each primer set by adjusting the annealing temperature or 
addition of 0.01 % gelatin and 0.1 % triton to the standard reaction buffer. Details 
of the primers and the conditions for PCR are laid out in Table 4.2. 
The size of exon 2 was not optimal for SSCP analysis and therefore internal primers 
(2-lb and 2-2b) were designed to amplify two overlapping fragments encompassing 
the whole of exon 2. 
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Table 4.2. Primers used for mutation analysis 
Primer Sequence Size PCR References 
(bp) conditions 
2F 5' tgtcgagcagtttcagcg 409 94 1' Baldwin et al. 
2R 5' cagtctgggagccaggag 63 1' 1992 
72 1' 
2F as above 220 94 1' 
2-lb 5' tgtggcggatgtggttgg 56 1' Own design 
72 2' 
2-2b 5' agggccgcgtcaaccagc 257 94 1' Own design 
2R as above 56 1' 
72 2' 
3F 5' cctgcccgcctgttctct 197 94 45" Morell et al. 
3R 5' cgactgactgtcgcgcct 63 45" 1992 
72 1' 
4F 5 ' agccctgcttgtctcaaccatgtg 241 94 45" Tassabehji et 
4R 5' tgccctccagtcacccagcaagt 61 45" al., 1992 
72 1' 
5F 5' gtcggagagagaacttgg 325 94 30" Own design 
5R 5' tgtctggactgaagtagg 56 30" 
72 l' 
6F 5 ' ttcatcagtgaaatc 264 94 30" Own design 
6R 5' tccaccagagaaatcgcc 46 30" 
65 l' 
7F 5' catgatggttgacaatc 286 94 30" Own design 
7R 5 ' ctggtatacagcaaatcg 46 30" 
65 l' 
4.2.1. Mutation screening 
4.2.la. Single stranded conformational polymorphism analysis 
The method used for SSCP analysis was based on the technique developed by Orita 
et al. (1989) with modifications to allow for non-radioactive detection of the single-
stranded nucleic acids by silver staining (Lohmann et al., 1992). 
Preparation of electrophoresis plates 
The glass plates were cleaned thoroughly with ethanol. The back plate was then 
wiped with acetone to prevent the gel sticking to this plate. The front plate was 
wiped with plate glue (500 µl 7MTMS (7-methacryloxypropyltrimethoxysilane), 50 
ml absolute ethanol) and left to dry for 2 min before bathing in ethanol to remove 
excess plate glue. The bathing process was repeated twice and the plate wiped dry 
with paper towel. The glass plates were assembled with 0.35 mm spacers and a 
0.35 mm well-forming comb. 
Electrophoresis 
SSCP analysis was performed by electrophoresis of the PCR product on a 0.5 x 
MOE gel (AT Biochem) in 0.5 x TBE buffer on a vertical gel apparatus. The 
samples were prepared by adding 5 µl of formamide loading dye (95 % formamide, 
10 mM NaOH, 20 mM EDTA, 0.02 % Bromophenol Blue, 0.02 % Xylene Cyanol) 
to 5 µl of PCR product. Samples were denatured at 95°C for 5 min before loading. 
Gel electrophoresis took place overnight (± 16 hours) at 4 - 6 W at room 
temperature (RT). Conditions were optimized for each PCR fragment. 
Silver Staining 
After termination of electrophoresis, the glass plates were prised apart, leaving the 
gel fixed to the glue treated plate. The gel was rinsed with distilled water and then 
soaked for 20 min in 0.1 % AgN03 solution. The excess AgN03 was rinsed off 
and the gel placed in developing solution (1.5% NaOH, 0.01 % Na borohydride, 
0.15 % fomaldehyde) for 10 min . To stop development, the gel was again rinsed 
with distilled water and fixed in a 0. 75 % NaC03 solution for 10 min. The banding 
pattern was noted and the gel transferred to Whatmann 3MM paper. A 20 min soak 
in 2 % NaOH was occasionally required to remove the gel from the glass plate. 
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4.2.lb. Heteroduplex analysis 
Preparation of glass plates 
The glass plates were prepared as for SSCP analysis and assembled with 1 mm 
spacers and a 1 mm well-forming comb. A 1 x MOE gel (AT Biochem) was 
prepared with a 0.6 x TBE electrophoresis buffer. The heteroduplex technique was 
carried out according to the protocol provided with the Hydrolink MOE gel. 
Sample preparation and electrophoresis 
After completion of the PCR, EDTA was added to a final concentration of 5 mM. 
Samples were denatured at 95°C for 3 min and then allowed to cool to RT. MOE 
gel loading buffer (AT Biochem) was added to the sample before loading. The gel 
was electrophoresed overnight in a 1 x TBE running buffer, at a maximum voltage 
of 20 V per cm of gel, maintaining the gel temperature below 40°C. DNA bands 
were visualized by silver staining as described above. 
4.2.2. Analysis of mutations 
Once a polymorphism was detected, the relevant exon was investigated further to 
determine the nature of the mutation. The initial strategy was to clone the variant 
and the normal exons into a vector and then to distinguish between normal and 
mutant alleles before sequencing. This procedure proved time consuming and was 
superseded by a more direct method for sequencing PCR products. 
4.2.2a. Sequencing of cloned PCR products 
PCR products were cloned using the PCR-script cloning kit (Stratagene) . The 
ligation reaction contained: 50 ng pCR-Script vector, 10 mM rATP, 10 units Sifl 
restriction enzyme, T4 ligase and a universal buffer, which were all provided in the 
kit. The PCR product ( 40 - 200 ng) was added to this reaction and incubated at 
room temperature for 1 - 2 hrs . The sample was then heated at 65°C for 10 min 
and stored on ice until the competent cells were ready. 
The Epicurian Coli XLl-Blue MRF kanr supercompetent cells, supplied with the 
cloning kit, were thawed on ice and aliquoted into prechilled Falcon 2059 
polypropylene tubes. 13-mercaptoethanol was added to a final concentration of 25 
mM to increase the transformation efficiency and the tubes placed on ice for 10 
min , swirling every two min. The ligated vector-PCR was added and the mixture 
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incubated on ice for 30 min. The cells were heat shocked at 42°C for 45 sec 
followed by cooling by placing on ice for 2 min. SOC medium (Appendix A) was 
added for expression at 37°C with shaking for 1 hr. The expression mixture was 
plated on Luria agar (Appendix A) plates containing X-gal, IPTG and 50 µg/ml 
Ampicillin and incubated overnight at 37°C. 
Plasmid extraction 
White bacterial colonies (indicative of B-galactosidase gene disruption) were picked 
and the plasmid extracted using the method of Ish-Horowicz and Burke (1981) . 
Plasmids were isolated from a 5 ml overnight bacterial culture (LB + Ap, 50 
µg/ml). The cells were harvested by centrifugation in an Eppendorf microfuge tube 
for 2 min. The pellet was resuspended in 0.2 ml Solution I (50 mM glucose, 25 
mM Tris-HCI, pH 8.0) and incubated at room temperature for 5 min. This was 
followed by the addition of 0.4 ml Solution 2 (0.2 M NaOH, 1 % (w/v) SDS), the 
solution mixed well by vortexing briefly and placed on ice for 5 min. To 
precipitate the chromosomal DNA and cellular debris, 0.3 ml pre-cooled Solution 3 
(5 M KOAc, pH 4.8) was added, mixed and left on ice for 5 min. This denatured 
DNA was removed by centrifugation for 10 min. The supernatant was transferred 
to a fresh tube, an equal volume of isopropanol was added and the plasmid DNA 
was precipitated by centrifugation for 10 min. The pellet was retained and washed 
with 70% ethanol, air dried and resuspended in 25 µl dH20. 
Plasmids underwent endonuclease digestion to verify the presence and size of the 
cloned insert in a reaction containing: 5 µ1 plasmid prep, 10 units Sacl, 10 units 
EcoRI, 20 µg RNase A and a restriction buffer. The fragments were resolved by 
electrophoresis at 80 V in a 1.5 % agarose gel with lx TBE running buffer. 
Pure plasmid preparations 
Plasmids were prepared for sequencing using the Nucleobond AX PC-Kit 100. A 
100 ml bacterial culture (LB, 50 µg/ml Ap) was grown overnight. The cells were 
pelleted by centrifugation and resuspended in 4 ml of buffer S 1 (50 mM Tris/HCI, 
10 mM EDTA, 400 µg RNase A/ml, pH 8.0). Four millilitres of buffer S2 (200 
mM NaOH, 1 % SDS) was added and the suspension mixed gently and incubated at 
room temperature for 5 min. Four millilitres of buffer S3 (2. 80 M KAc, pH 5 .2) 
was added and the solution mixed by shaking until homogeneous. The cell debris 
and genomic DNA was removed by centrifugation at high speed and 4 °C for 38 
min. The supernatant was removed carefully from the white precipitate and loaded 
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on a Nucleobond cartridge, equilibrated with buffer N2 (100 mM Tris/H3P04, 
15% ethanol, 900 mM KCl, pH 6.3) . The cartridge was washed twice with 3ml 
buffer N4 (100 mM Tris/H3P04, 15% ethanol, 1300 mM KCl, pH 6.3) . The 
plasmid was eluted with 2 ml buffer N5 (100 mM Tris/H3P04, 15% ethanol, 1000 
mM KCl, pH 8.5) . The purified plasmid was precipitated with 0. 7 volumes 
isopropanol and pelleted by centrifugation, washed with 70% ethanol and 
resuspended in dH20. All buffers were supplied with the kit. 
Sequencin~ 
The cloned insert was amplified, using the original primers and conditions for exon 
amplification. SSCP analysis was performed on the PCR products of these clones 
to distinguish between clones carrying inserts of normal alleles and those carrying 
the mutant alleles. Bacterial colonies of both the normal and mutant alleles clones 
were cultured to produce pure plasmids preparations for the purpose of sequencing. 
Clones were sequenced using the Sequenase version 2.0 (USB) system. Three 
micrograms of purified plasmid DNA was denatured and added to an annealing 
mixture containing sequencing primer (one of the original set of primers used for 
the exon amplification) and reaction buffer. Annealing took place by heating the 
sample to 65°C for two minutes and then cooling slowly to 35°C. At this point the 
termination mixture for each nucleotide was aliquoted into 0.5 ml Eppendorf tubes 
and prewarmed to 37°C. The labeling mixture was prepared by adding labeling 
mix, [S35] dATP and Sequenase polymerase to the annealing mixture. Radioactive 
labelling took place at 15°C for 5 min. Strand synthesis was terminated by adding 
labeling mixture to each of the four termination tubes and incubating at 37°C for 5 
min. The reaction was stopped by the addition of Stop Solution. The samples were 
heated to 72°C for 2 min before loading onto a sequencing gel. 
The sequencing gel apparatus was prepared by wiping both gel plates with ethanol 
and then with acetone to prevent the gel from sticking to the plates. The glass 
plates were assembled using 0.35 mm spacers and a 0.35 mm sharks tooth comb. A 
denaturing gel was made using Long ranger gel solution (AT Biochem) at 8 % with 
1.2 x TBE as the gel buffer and 0.6 x TBE as the running buffer to improve spatial 
resolution. Electrophoresis of the samples was carried out at 70 W constant power, 
which kept the gel temperature below 50°C. The gel was transferred to Whatmann 
3 MM paper, dried and exposed to X-ray film (Agfa, Curix). Intensifying screens 
were removed from the X-ray cassette, which improved the sharpness of the bands, 
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but required longer exposure (2-3 days). The X-ray cassette was placed at - 70°C 
for the exposure time. 
4.2.2b. Direct Sequencing of PCR products 
Extraction of PCR product 
Mutant and normal single-stranded alleles were excised from the silver-stained 
SSCP gel and eluted in 50 µl dH20. Two microlitres of this eluent was used in a 
PCR reaction to amplify the allele. The PCR product was electrophoresed 
horizontally at 80 V on a 1.5% agarose gel in TBE buffer. Bands were cut out of 
the gel, macerated and placed in an Eppendorf tube. An equal volume of phenol 
(pH 8.0) was added and mixed with the agarose by shaking. The tube was placed on 
dry ice for 10 min and then centrifuged for 10 min to remove the agarose. The 
aqueous phase was transferred to a fresh Eppendorf tube and mixed with equal 
volumes of phenol and chloroform:isoamyl alcohol (24: 1). The aqueous phase was 
removed after centrifugation and an equal volume of chloroform:isoamyl alcohol 
was added to eliminate any traces of phenol. After centrifugation, the DNA from 
the aqueous phase was ethanol precipitated with LiCl (1/10 volume 4M LiCl + 2.5 
volumes of EtOH) . The resulting DNA pellet was washed in 70% ethanol, dried 
and resuspended in 10µ1 dH20. 
Seguencine 
Sequencing was accomplished using the direct incorporation protocol of the fmol 
DNA sequencing system (Promega) . For each set of sequencing reactions, four 
tubes were designated for the appropriate nucleotide mix containing both the deoxy-
and dideoxynucleotide triphosphate. Two microlitres of the purified PCR template 
was combined with fmol 5 x sequencing buffer (250 mM Tris-HCl , 10 mM 
MgCl2) , 10 pmol of one of the primers used for the exon being sequenced, a-32p 
dCTP and 5 units of Taq polymerase (provided in the kit) . The template mixture 
was dispensed into each of the four nucleotide tubes, liquid parafin layered on top 
and the tubes placed in a thermocycler. The primer length and GC-content 
determined the amplification conditions used for the PCR reaction . For a primer 
less than 24 bp or with a GC-content less than 50% the conditions were : 95 °C for 
2 min then , 95 °C for 30 sec, 42°C for 30 sec, 70°C for 1 min for 30 cycles, then 
4 °C. For a primer greater than 24 bp or a GC-content greater than 50% 
amplification was a two step reaction: intial denaturation 95°C for 2 min then , 
95 °C for 30 sec, 70°C for 30 sec for 30 cycles, then 4 °C. After the reaction was 
59 
completed fmol Stop solution (10 mM NaOH, 95 % formamide, 0.05 % 
bromophenol blue, 0.05 % xylene cyanol) was added. The samples were heated to 
70°C for 2 min before loading on a Long Ranger sequencing gel (preparation and 
electrophoresis as in 4.2.2a). 
The difference in sequence between the normal and altered alleles was analysed to 
determine whether the amino acid sequence was disrupted at the site of the sequence 
change. With the aid of the map component of Genetics Computer Group (GCG) 
package, a mutation could be confirmed in a family by determining whether a 
restriction site was generated or obliterated by the change in sequence. 
4.2.3. RNA Studies 
4.2.3a. Transformations 
Blood (10 ml) was collected in heparinised tubes. The blood was diluted 1: 1 with 
growth media (Gibco Hams FlO, 10% Gibco Fetal calf serum). Five millilitres 
ficoll (Histopaque 1077) was aliquoted into 15 ml tubes and 10 ml of the diluted 
blood layered on top. Separation of the blood phases was by low speed 
centrifugation for 20 min . The white blood cells were removed and transferred to a 
clean tube. Growth media was added to eliminate any remaining ficoll and the cells 
pelleted by low speed centrifugation. The supernatant was discarded and the 
washing repeated. The cells were resuspended in transformation media (2.5 ml 
growth media, 2.5 ml Epstein Barr virus, 4 µglml phytohaemogluttinin) and placed 
in a 50 ml tissue culture flask. Viral transformation occurred over three days in a 
5% CO2 incubator at 37°C. The transformation media was then removed and 
replaced with growth media. Incubation and feeding continued until a dense culture 
was obtained. The cells were then pelleted by centrifugation and washed once with 
growth media. The supernatant was discarded and the cells resupended in 6 ml 
freezing media (Gibco Hams FlO, 20% Fetal Calf serum , 10% glycerol, 50 g/1 
penicillin, 30 g/1 streptomycin, 25 g/1 neomycin) . Resupended cells were aliquoted 
in 1 ml amounts into 2 ml cryotubes. The cells were frozen and stored in liquid 
nitrogen for further use. 
4.2.3b. RNA extraction from lymphoblasts 
The extraction of RNA was by the method of Chomzynski and Sacchi (1987) . 
Transformed lymphocyte cultures were centrifuged and the supernatant discarded. 
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The cells were washed in saline. 1 ml of solution D (4 M guanidium thiocyanate, 
25 mM sodium citrate, 0.5 % sarkosyl, 0.1 M 2-mercaptoethanol) was added with 
0.1 ml 2 M sodium acetate, 1 ml water saturated phenol, 0.1 ml 
chloroform:isoamylalcohol 49: 1). The tube was shaken vigorously and cooled on 
ice for 15 min. Centrifugation pelleted all the cell debris and left the RNA in the 
aqueous phase. The RNA from the aqueous phase was precipitated with ethanol on 
dry ice or stored in ethanol at -70°C until needed. 
4.2.3c. cDNA synthesis and amplification 
The reverse transcription reaction was carried out using 10 µg of total RNA. 1 µg 
oligo-dT primer (Genosys) and 1 µg random hexanucleotide primer (Genosys) were 
added to the RNA in a 10 µl volume with a final concentration of 5 % DMSO and 
heated to 65°C for 3 min to denature the sample and then cooled on ice. A mixture 
was made containing 10 units RNasin, 200 units MMLV reverse transcriptase 
(Gibco BRL), dNTP stock to a final concentration of 200 µMand 5% DMSO in a 5 
x dilution of the reaction buffer (0.25 M Tris-HCl, 0.375 M KCl, 15 mM MgCl2 -
Gibco BRL). This mixture was added to the RNA sample and incubated at 37°C 
for 1 hour. Following this, the sample was denatured at 95 °C for 3 min and chilled 
on ice to prevent reannealing. A further 200 units of MML V reverse transcriptase 
were added and the reaction incubated at 37°C for 1 hour. This step was repeated 
and reverse trancription was completed after the third hour of incubation. The first 
PCR amplification reaction, using the outside set of nested primers, contained 5-10 
ul of reverse transcribed RNA, 10 pmol of each primer, 5% DMSO, 200 µM 
dNTP, 2 units Taq polymerase (Gibco BRL), 2 units 
Taq extender (Stratagene) in a 1 x Taq extender reaction buffer (10 x: 200 mM 
Tris-HCl, 100 mM KCl, 100 mM (NH4)2S04, 20 mM MgCl2, 1 % Triton X-100, 
1 mg/mlbovine serum albumin - Stratagene). The reaction underwent 30 cycles of 
amplification at 94°C for 30 sec, 56°C for 30 sec and 65°C for 1 min. Using 2 µl 
of this reaction, a further 30 cycles of amplification were carried out under the same 
reaction conditions, using the inside set of the nested primers. The primers used for 
PAX3 amplification were: HUP2-4 5'-ggccagggccgcgtcaac and Pax3-1 5'-
ctagaacgtccaaggctt (antisense) as the outside set (Hoth et al . , 1993) and Ex2cF 5 '-
atacgtcctggtgccatcg and Ex6cR 5'-cttcctccatcttgcacgg (antisense) as the inside pair 
of nested primers (own design) . The product was observed under UV light on a 2% 
agarose gel electrophoresed in TBE buffer. 
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CHAPfER 5. RESULTS AND DISCUSSION OF MUTATION 
ANALYSIS 
5.1. MUTATION RESULTS 
The results of the mutation analysis are described m the sequential order of the 
exons of PAX]. 
A polymorphism in exon 2 was found to track with the disorder in WS family 2. 
Some of the affected individuals (IV-1 and Ill-8) seemed to be homozygous for this 
change as indicated on the SSCP gel in Figure 5 .1. 
II • 
'. I 
I I 
; .
Ill • 
' - 1 
I I 
f / • 
I 
I I • 
LJ··· r -• . 
I 
-. I - -
' . !J '1 •._ 
. . 
I 
; 
., 
I - . 
' I 
• • • 
Figure 5.1 . SSCP analysis of exon 2 in WS 2. All affected individuals inherit 
the polymorphic allele from an affected parent. An asterisk indicates the 
individuals from whom blood was taken. O = male, O = female, • = affected 
male, • = affected female. 
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Direct sequencing of the homozygous band as well as the heterozygous bands 
revealed a C to T change at codon 43 (Figure 5.2.). The change does not affect the 
amino acid sequence. This silent polymorphism has been previously reported by 
Tassabehji et al. (1994) and, although it is non-pathogenic, it confirms linkage of 
WS in family WS 2 to PAX3 as the polymorphism tracks with WS I in this family. 
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Figure 5.2. Direct sequencing of the normal and mutant exon 2 bands in WS 2. 
The polymorphism can be used diagnostically in WS 2, provided the genotype of 
the affected parent and the spouse can be obtained. The SSCP shows that the 
mother of III-11, II-5, is negative for the polymorphism and is therefore unaffected. 
III-11, who is also unaffected, has the polymorphism which, therefore, must have 
been inherited from the father. Only a polymorphic allele inherited from an 
affected individual within the family is associated with an affected phenotype. 
The primers designed to amplify two fragments encompassing exon 2, for optimal 
SSCP analysis of this exon, did not reveal any other changes, other than the 
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polymorphism in WS family 2, which was also detected using the orignal exon 2 
primers. 
SSCP analysis of exon 3 indicated changes in WS 4 and in a sporadic individual, 
WS 44. l. Expanding the analysis to include all the members of WS 4, revealed that 
the mutation arose in the second generation and was inherited with the disorder in 
the subsequent generations (Figure 5.3.). 
II 
JU 
IV 
1 2 3 4 5 6 7 8 9 10 11 12 · 13 
,. 
65 
Figure 5.3. SSCP analysis of exon 3 in family WS 4. O = male, O = female,• 
= affected male, • = affected female. 
For comparison, the results of heteroduplex analysis of WS 4 are shown in Figure 
5.4. The difference in banding pattern between the normal and affected individuals 
in this family was more apparent when using SSCP analysis . 
,-·1 e i , --, -· 
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---,-. --.--6 ------.-~ 
D • 
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Figure 5.4. The results of heteroduplex analysis in WS 4. The generation 
numbers ref er to the pedigree in figure 3.1. a = male, o = female, • = 
affected male, • = affected female. 
The PCR fragment of exon 3, from unaffected and affected family members, was 
cloned. The clones were screened by SSCP analysis to determine which carried the 
variant allele and which the normal. Sequencing indicated a transition mutation, as 
shown in Figure 5.5, with guanine being replaced by cytosine. 
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Figure S.S. Sequencing of cloned alleles of exon 3 in WS 4. 
The mutation could be confirmed in all affected individuals in this family as the 
base substitution interrupts an Rsal restriction site, inhibiting enzyme cutting of 
mutated alleles. All affected individuals were shown to carry a normal allele cut 
with Rsal and an uncut mutated allele as shown in Figure 5.6. 
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~43bp 
Figure 5.6. Endonuclease digestion of the exon 3 PCR fragment of WS 4 with 
Rsal. The numbers correspond to the pedigree in Figure 5.3. 
The mutation was located at the exon 3-intron boundary, in the paired domain of 
PAX3 and has been described in Butt et al., 1994. The boundary between exons 
and intrans contains splice site consensus sequences. Padgett et al. (1986) showed, 
in a survey of approximately 400 vertebrate genes, that the 5' consensus has a 
virtually invariant AG dinucleotide as the last 2 base pairs of the exon, and a highly 
conserved (100%) GU as the first dinucleotide of the intron. · The mutated allele in 
affected WS 4 family members involves substitution of the first G of the intron 
dinucleotide for an A. This splice site consensus alteration has been reported to 
cause a number of other genetic diseases (Krawczak et al., 1992). The net effect of 
this intronic G to A transition is an aberration in mRNA processing. 
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The mutation in the sporadic individual (WS 44.1) in exon 3 was shown, by 
sequence analysis to occur at the same position as the mutation in WS 4. The splice 
site was disrupted by the insertion of 7 bp. The other members of this individual's 
family were all clinically normal and SSCP screening confirmed that they did not 
have the mutation. The banding pattern of the SSCP gel and the sequence analysis 
are shown in Figure 5. 7 . 
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Figure 5.7. Analysis of exon 3 in WS 44.1. (a) A comparison of the SSCP 
banding patterns of exon 3 in a normal individual, WS 4 and the sporadic WS 
44.1. (b) Sequencing autoradiograph showing the 7 hp insertion in the mutant 
allele of WS 44.1. (c) The site of the insertion disrupting the splice site at the 
exon 3-intron 3 boundary. 
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Another splice site mutation was located at the intron 3-exon 4 boundary in a 
sporadic individual. An A to G transition was identified in the 3' splice acceptor 
consensus sequence of intron 3, converting an invariant AG to GG as indicated in 
Figure 5.8. Only one affected member, WS 14.2, of this family was available for 
investigation. 
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Figure 5.8. Sequence analysis of the intron 3-exon 4 boundary in a sporadic 
individual. 
Mutation screening of the homeodomain was initiated after the exon-intron 
boundaries in this region had been identified (Tassabehj i et al., 1994). SSCP 
screening localised the mutation in WS l to exon 5. The family pedigree with the 
mutation tracking with the affected members is illustrated in Figure 5.9. 
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Direct sequencing showed a single base substitution (G to A) in the 5' region of the 
homeodomain, preceding the first helix (Figure 5.10.). The codon for an arginine 
residue at aa position 223 was converted to that for glutamine. This amino acid is 
100% conserved in paired-type homeodomains genes, the murine Hox genes and in 
the Drosophila Antennapedia, engrailed and bicoid homeodomains. 
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Figure 5.10. Sequence analysis of the mormal and affected alleles of exon S in 
WS1 
Restriction analysis using the GCG package indicated that no known restriction 
enzyme sites were abolished or created by the change. For confirmation of the 
mutation for diagnostic purposes, an allele specific oligonucleotide (ASO) could be 
designed to detect this mutation. The method has been described by Hoth et al. 
(1993). 
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Two families, WS 3 and WS 48, and a sporadic individual, were shown to have 
mutations in exon 6. The conformational change in WS 3 is shown in Figure 4.11. 
I 
Il 
n1 
* 
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* * 
Figure 5.11. SSCP analysis of exon 6 in WS 3. An asterisk indicates the 
individuals from whom blood was taken. O = male, 0 = female, a = affected 
male, • = affected female. 
Sequencing of the normal and mutant bands indicated the deletion of a single base 
pair (Figure 5.12.); the T at the first position of a phenylalanine codon (aa number 
294). The codon reading frame is disrupted by the deletion, creating a nonsense 
message that is terminated prematurely by the creation of a stop codon in exon 7 at 
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aa 380. An A val/ site is created by the change and can be used as a confirmation of 
the sequencing results. 
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Figure 5.12. Sequence analysis of the mutant and mormal exon 6 alleles from 
members of WS 3. 
The family, WS 48, in which rare phenotypic associations occured together with the 
usual WS characteristics, was found to have a conformational change in exon 6. 
The SSCP change co-segregates with the disorder in this family as shown by the 
results in Figure 5. 13. 
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Initial sequencing of both the forward and the reverse strands of the normal and 
mutant alleles has failed to reveal a change in the DNA sequence. 
A conformational change in exon 6 was also noted in a WS type I sporadic 
individual , WS 18.1. No other variant banding patterns were observed in exon 6 
in 35 unrelated individuals with WS or in 10 normal, unrelated controls. SSCP 
analysis of exon 7 revealed only one individual with a variant banding pattern. This 
sporadic individual, WS 22.1, has a normal WS type I phenotype. 
5.2. DISCUSSION OF MUTATION ANALYSIS 
There is a high level of intragenic heterogeneity of mutations causing WS I. The 
exonic mutations in the Southern African families in this study are all unique when 
compared to those reported worldwide. The splice site mutations, however, show 
some analogies to mutations reported in both mouse and man. 
A similar mutation to that found in the family WS 4 was reported by Tassabehji et 
al. (1994). The invariant GT donor splice site at the 5' end of intron 3 was 
abolished by the substitution of the G for a T, while in WS 4 reported here, the G is 
replaced by an A. In both cases, as shown in Table 4.1 , section 4.1., abberant 
splicing is predicted to occur. The mRNA transcript would either exclude exon 3 or 
include intron 3 and utilize a cryptic splice site in the flanking DNA. K.rawczak et 
al. (1992) noted that in 29 cases where the point mutation occurred at the 5' splice 
site, 16 showed exon skipping of the preceding exon, while in 7 cases a cryptic 
splice was used. The remaining 5 cases produced a mixture of exon-skipped and 
cryptically-spliced transcripts in differing proportions. 
The original Sp mouse was shown to have a mutation at the 3' end of intron 3 
(Epstein et al., 1993). This mutation abrogated the normal splicing of intron 3 by 
modifying the 3' acceptor consensus from the invariant AG to TG . The mutation 
identified in the sporadic individual, WS 14.2, and in a family reported by 
Tassabehji et al. (1994) modifies the 3' acceptor from AG to GG. The 3' splice site 
mutations analysed by Krawczak et al. (1992) indicate that this mutation would 
cause skipping of the downstream exon , exon 4, and/or utili sation of a cryptic splice 
site. The results of RNA studies on the Sp/Sp mouse by Epstein et al. (1993) 
showed that 4 transcripts were produced: 2 using cryptic splice sites in the 
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downstream exon and disrupting the reading frame, 1 retaining intron 3 and 1 
transcript lacking exon 4. The only in-frame transcript produced was the exon 4 
deletion. In this instance, the 3' end of the gene would still be functional; only 
exon 4 containing the octapeptide repeat would be missing . A similar consequence 
is expected with the human 3' splice site mutations. 
An experiment to confirm this hypothesis was undertaken for WS 4 and WS 44.1. 
Detailed methods are given in section 4.2.3. Lymphocytes , isolated from veinous 
blood from affected individuals, were transformed with Epstein Barr virus in an 
endeavour to restore the production of PAX 3 transcripts (Hoth et al., 1993). The 
RNA was extracted from the immortalised cells and was reverse transcribed. A 
nested PCR reaction was set up to amplify the PAX 3 cDNA. Analysis of the size 
differences of the resultant PCR products would confirm the RNA processing 
dysfunction. Products of this PCR reaction were not of the expected sizes, though 
it has been observed that a number of transcripts are produced from cDNA from 
affected individuals in WS 4. These PCR products must be sequenced before any 
conclusions can be made. 
Of the 7 Southern African WS type I families , 4 were characterised with regard to 
the pathogenic mutation in PAX3 and one family showed a non-pathogenic 
polymorphism. This emphasises the fact that SSCP screening is not 100 % efficient 
in the detection of DNA alterations. Heteroduplex analysis was employed, but 
proved no more effective than SSCP analysis and an alteration in the banding 
pattern of SSCP's was more conspicuous than a heteroduplex banding pattern. 
SSCP was favoured as the screening method because of its simplicity and 
furthermore, the equipment available meant that far more samples could be screened 
by SSCP analysis than heteroduplex analysis. 
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CHAYfER 6. COMMENT AND FUTURE PROSPECTS 
The aim of this study was to elucidate the cause of WS in Southern African 
families. The findings are discussed in detail at the end of each chapter. 
The WS type I families, differentiated from type II by the mean WARD index of 
the family, were shown to be linked to a developmental control gene, PAX3. 
Molecular screening of this gene elucidated the pathogenic mutations underlying the 
disorder in some of the type I families . Intragenic heterogeneity was demonstrated 
in this population, as it had been in others, by the fact that the mutations were 
widely spread over different exons of PAX3. Exon 2, which encodes part of the 
paired domain, contained most of the mutations reported by the International 
Waardenburg Consortium. In the SA sample of patients, there was no such bias; 
conversely the homeodomain was found to have more mutations than the 5' end of 
the gene. The sample size in this study is not large enough to warrant a general 
statement about the position of PAX3 mutations causing WS, though it is worthy of 
comment. The position of the mutations, however, did not influence the phenotype 
and no correlations could be made as to the expressivity of one characteristic over 
another in respect to the location of the intragenic defect. 
The SSCP and heteroduplex techniques have been employed for exonic screening in 
this study. Sequence heterogeneity was detected in 5 out of the 7 WS type I 
families. It has been shown that SSCP analysis detects 70 - 95 % of mutations in 
PCR products of 200 bp or less (Michaud et al., 1992) and therefore it is not 
unexpected that mutations in PAX3 have not been detected in some of the WS type I 
families. There is also the possibilty that the mutations in these families lie in exons 
1 or 8, which have not been screened. A more efficient method for mutation 
detection , the Hydroxylamine Osmium Tetroxide chemical cleavage method (HOT), 
has been described by Cotton (1988). This method involves the use of highly toxic 
chemicals as well as r-P32. Saleeba et al. (1992) optimised the technique without 
using radioactivity , by visualising the DNA with silver stain. Although the HOT 
method is time consuming and involves a few different DNA manipulations, it is 
said to be 100 % efficient (Grompe, 1993). It is advisable to use SSCP analysis as 
an intial screen , but for those families where mutations have not been detected, it 
would be pertinent to employ the HOT method. 
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Families with WS type II were not linked to PAX3. The clinical distinction between 
WS type I and type II is of relative importance for genetic counselling, as type II 
individuals have a higher incidence of deafness. WS type II shows non-allelic 
heterogeneity, as reported by Hughes et al. (1994), when describing a gene (MJTF) 
defective in some, but not all, WS type II families. The SA families were also 
found to be heterogeneous, with only one out of the three WS type II families 
having a strong probability of being linked to the MITF gene. 
The likelihood of chromosome 20 containing a gene responsible for WS type II in a 
SA family was also investigated. Haplotype analysis of WS family 27 indicates a 
strong possibility of a gene being located at 20q13. Fine mapping of this region 
with further polymorphic markers is neccessary before this gene can be identified. 
Intrafamilial variability of the phenotypic manifestations in both WS I and WS II is 
commonplace. This indicates that modifying genes, expressed at the same time as 
PAX3 (or MITF) may be involved in determining the phenotype. Another 
possibility is that epigenetic factors may modify expression. The temporal and 
spatial expression of developmental genes, such as those involved in WS, is very 
precise. These genes form part of a cascade of regulated events, functioning in the 
control of expression of genes during development. The production of defective 
proteins early in the cascade would have a more widespread effect than proteins 
which may be produced late in development. 
The conserved domains of PAX3 indicate that it functions as a DNA binding 
protein. Prokaryotic proteins that control transcription, such as the E.coli cAMP 
receptor protein, have been structurally examined by X-ray crystallography to 
establish how specific DNA binding occurs (Schleif, 1988). It was determined that 
the helix-turn-helix motif angles the protein in such a way that contact with specific 
base pairs can be attained. The homeodomain, which consists of 3 helices separated 
by turns, is predicted to bind DNA in a similar fashion. A single amino acid in the 
third helix (residue 9) confers the DNA binding specificity of the homeodomain 
(Treisman et al., 1989). Proteins with the same residue 9 amino acid as PAX3 have 
been shown to bind the Drosophila e5 recognition sequence. The e5 sequences have 
two recognition elements, one recognised by the paired domain and one by the 
homeodomain. High affinity binding is achieved when both protein domains are 
present; these domains, however, may also function individually and initiate 
transcription of other distinct genes (Goulding et al., 1991). 
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The MITF gene is also thought to encode a transcription factor (Hughes et al., 
1993; Hodgkinson et al., 1993). The protein structure is that of a basic helix-loop-
helix-zipper protein, which function as homodimers or heterodimers with related 
proteins to bind DNA. MITF is expressed in mouse embyros in the pigment layer 
of the retina, in cells surrounding the otic vesicle, in hair follicles and in the 
embryonic heart (Hodgkinson et al., 1993) and also in several adult tissues (Hughes 
et al., 1993). Like PAX3, the probable function of MITF during development is in 
transcriptional regulation of genes involved in controlling the migration, 
proliferation or diffentiation of melanoblasts. 
Molecular genetics has played a vital role m locating genes involved in the 
pathogenesis of WS. Many of the mutations in these genes underlying the protein 
defect have now been characterised. Positive linkage and mutation detection make 
it possible to offer antenatal diagnosis, although, the severity of the phenotype can 
not be predicted. 
Studies, such as this one, provide the basis for further investigation of the events 
that occur during embryogenesis and the genes that regulate these events during 
normal development. This appraoch, in turn, may provide clues as to the 
abnormalities during embryogenesis that give rise to neural tube defects and other 
medically important developmental anomalies. 
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